“Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the company’s strategic direction and contribute to its differentiation, not just in order to be bigger, ” Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) president and CEO Erez Vigodman said at a conference of Sanara Ventures, a joint technology incubator of Teva and Royal Philips Electronics focusing on medical equipment and technologies. Teva is in the midst of an attempt to take over Mylan Pharmaceuticals (MYL), its competitor, in a deal worth over $40 billion.
In a talk with Royal Philips CEO Frans van Houten and Sanara CEO Assaf Barnea, Vigodman was asked about the mergers and acquisitions trend in the industry (there were several recent mega-deals in the medical equipment industry)…
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Published by Globes [online], Israel business news – www.globes-online.com
